Boeing Company (The) (BA)

Key Updates

Boeing shares have declined a further 2.33% to $222.04 since the August 17 report ($227.34), extending a multi-week pullback from the post-earnings/Farnborough peak of $237.52 reached on August 4. No new material news has emerged since the last report; the six articles referenced remain the Q2 earnings release (July 28), the Farnborough order win (July 31), Q2 earnings commentary from Morningstar/CNBC/FT (July 28-31), and the MSC Air Cargo/Uganda Airlines/Luxair order announcements (July 21), all previously incorporated into prior analyses. The current move therefore appears to reflect continued profit-taking and consolidation rather than a fresh fundamental catalyst, with the stock now roughly 6.5% below its early-August high while still up 6.0% over the trailing month.

Current Trend

Boeing is up 2.27% YTD (implied YTD reference price ~$217), but has retraced sharply from the ~$237-238 peak reached in the days following the July 28 earnings release and Farnborough order wins. The stock is down 3.96% over 5 days and 4.99% over 6 months, indicating that the post-earnings rally has partially reversed. The 1-day move (-0.46%) suggests the pace of decline is moderating. Implied recent price levels: 1-month low ~$209 (pre-earnings), 5-day high ~$231, current price $222.04. Near-term support sits near the YTD reference level of ~$217, with a secondary support zone at the 1-month low of ~$209. Resistance is now established at the $231-$237 range, representing the early-August rally highs.

Investment Thesis

The thesis remains centered on Boeing's operational turnaround under CEO Kelly Ortberg: production rate increases (737 MAX cap raised to 47/month), a record $715 billion backlog providing multi-year revenue visibility, improving free cash flow trajectory (targeting ~$1.5 billion in 2026 and >$10 billion by 2028), and normalization of regulatory oversight (restored self-certification authority for 737 MAX/787). Commercial momentum, evidenced by the Farnborough order win over Airbus and continued bilateral deals (MSC Air Cargo, Uganda Airlines, Luxair), supports the demand side of the thesis, while execution risk on 777X/MAX-10 certification and persistent commercial-segment losses remain the key offsetting risks.

Thesis Status

The thesis is intact but momentum has stalled. Fundamentals disclosed in the Q2 print (record backlog, improving FCF, rising deliveries) remain supportive, and no negative fundamental developments have surfaced since the last report. However, the inability of the stock to hold the post-earnings gains — now having given back roughly two-thirds of the rally from the pre-earnings low near $209 to the peak near $237 — suggests the market is reassessing near-term risk, likely tied to the magnitude of the Q2 core loss (-$0.76/share vs. -$0.30 consensus) and lingering commercial-segment unprofitability rather than any new adverse catalyst.

Key Drivers

No new company-specific catalysts have emerged since the August 17 report. The prevailing drivers remain: Q2 results showing a wider-than-expected core loss but better-than-expected free cash flow (CNBC); record $715 billion backlog and 171 commercial deliveries (PR Newswire); the Farnborough order win over Airbus reinforcing customer confidence in the turnaround (Business Insider); the 737 MAX 10 assembly start and FAA production cap increase to 47/month (Financial Times); and Morningstar's upward fair value revision to $246 (Morningstar). The current pullback appears to be a technical retracement of these prior catalysts rather than a response to new information.

Technical Analysis

Boeing has fallen from a rally high of $237.52 (August 4) to $222.04, a decline of approximately 6.5% over two weeks, while remaining up 6.0% on a 1-month basis. The 5-day decline of 3.96% indicates accelerating selling pressure into this report, though the 1-day change (-0.46%) shows some stabilization. The stock is trading just above its implied YTD support level (~$217), with the 1-month low (~$209) as the next support if the current retracement continues. Resistance is now defined by the $231-237 zone, the site of the failed August rally attempt. A break below $217 would erode the YTD gain and signal a deeper technical correction; a reclaim of $231 would be the first sign of trend resumption.

Bull Case

• Record backlog provides multi-year revenue visibility: Total backlog reached $715 billion, including over 6,200 commercial aircraft valued at $597 billion, underpinning long-term production and revenue growth (PR Newswire).
• Farnborough order win signals restored customer confidence: Boeing secured 173 aircraft orders versus Airbus's 154, its first major airshow victory in four years, reflecting airline confidence in Ortberg's turnaround (Business Insider).
• Free cash flow inflection ahead of schedule: Q2 free cash flow of $631 million significantly beat consensus expectations of a $177 million burn, with management guiding to ~$1.5 billion FCF for 2026 and over $10 billion by 2028 (CNBC, Morningstar).
• Production ramp and regulatory normalization: The FAA raised the 737 production cap to 47 jets/month and restored Boeing's ability to self-issue airworthiness certificates for the 737 MAX and 787, easing a key operational bottleneck (Financial Times).
• Valuation upgrade from Morningstar: Fair value estimate raised to $246 from $238, with the stock trading within 10% of this revised target, suggesting further upside potential (Morningstar).

Bear Case

• Core loss significantly wider than expected: Q2 adjusted loss of $0.76/share missed consensus of a $0.30 loss, driven partly by a $280 million Air Force One charge, raising concerns about earnings quality (CNBC).
• Commercial segment remains unprofitable: Commercial Airplanes posted an operating margin of -2.7%, with Leeham Co estimating Boeing lost an average of $2.8 million per plane on the 314 units delivered in H1 2026 (Financial Times).
• Defense program charges persist: The Air Force One program's $280 million charge contributed to a $15 million loss in Defense, Space & Security despite 13% sales growth, highlighting ongoing fixed-price contract risk (Business Insider).
• Execution risk on certification and ramp timelines: 777X and 737 MAX-7/MAX-10 certifications are not yet complete, and the new Everett 737 line is initially producing only one jet per month against a $1 billion investment, posing risk to the 52/month production target (Financial Times).
• Technical momentum has faded: The stock has retraced roughly 6.5% from its August 4 peak of $237.52 to $222.04, with a 3.96% decline over the past 5 days despite no new negative catalysts, and remains down approximately 8% over the trailing year per prior reporting (Business Insider).